| Year |
Citation |
Score |
| 2023 |
Cooney TR, Farrand K, Draper SL, Anderson RJ, Rendle PM, Hermans IF, Compton BJ, Painter GF. Synthesis and Biological Evaluation of Peptide-Adjuvant Conjugate Vaccines with Increasing Antigen Content. Bioconjugate Chemistry. PMID 37022946 DOI: 10.1021/acs.bioconjchem.3c00106 |
0.336 |
|
| 2023 |
Pankhurst TE, Buick KH, Lange JL, Marshall AJ, Button KR, Palmer OR, Farrand KJ, Montgomerie I, Bird TW, Mason NC, Kuang J, Compton BJ, Comoletti D, Salio M, Cerundolo V, ... ... Hermans IF, et al. MAIT cells activate dendritic cells to promote T cell differentiation and induce humoral immunity. Cell Reports. 42: 112310. PMID 36989114 DOI: 10.1016/j.celrep.2023.112310 |
0.409 |
|
| 2023 |
Dasyam N, Sharples KJ, Barrow C, Huang Y, Bauer E, Mester B, Wood CE, Authier-Hall A, Dzhelali M, Ostapowicz T, Kumar R, Lowe J, Maxwell A, Burn OK, Williams GM, ... ... Hermans IF, et al. A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma. Cancer Immunology, Immunotherapy : Cii. PMID 36881133 DOI: 10.1007/s00262-023-03400-y |
0.393 |
|
| 2022 |
Burn OK, Farrand K, Pritchard T, Draper S, Tang CW, Mooney AH, Schmidt AJ, Yang SH, Williams GM, Brimble MA, Kandasamy M, Marshall AJ, Clarke K, Painter GF, Hermans IF, et al. Glycolipid-peptide conjugate vaccines elicit CD8 T-cell responses and prevent breast cancer metastasis. Clinical & Translational Immunology. 11: e1401. PMID 35795321 DOI: 10.1002/cti2.1401 |
0.315 |
|
| 2022 |
Prasit KK, Ferrer-Font L, Burn OK, Anderson RJ, Compton BJ, Schmidt AJ, Mayer JU, Chen CJ, Dasyam N, Ritchie DS, Godfrey DI, Mattarollo SR, Dundar PR, Painter GF, Hermans IF. Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect. Oncoimmunology. 11: 2081009. PMID 35712122 DOI: 10.1080/2162402X.2022.2081009 |
0.475 |
|
| 2022 |
Meijlink MA, Chua YC, Chan STS, Anderson RJ, Rosenberg MW, Cozijnsen A, Mollard V, McFadden GI, Draper SL, Holz LE, Hermans IF, Heath WR, Painter GF, Compton BJ. 6″-Modifed α-GalCer-peptide conjugate vaccine candidates protect against liver-stage malaria. Rsc Chemical Biology. 3: 551-560. PMID 35656478 DOI: 10.1039/d1cb00251a |
0.324 |
|
| 2021 |
Burn OK, Pankhurst TE, Painter GF, Connor LM, Hermans IF. Harnessing NKT cells for vaccination. Oxford Open Immunology. 2: iqab013. PMID 36845569 DOI: 10.1093/oxfimm/iqab013 |
0.524 |
|
| 2021 |
Jarvis EM, Collings S, Authier-Hall A, Dasyam N, Luey B, Nacey J, Painter GF, Delahunt B, Hermans IF, Weinkove R. Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy. Frontiers in Immunology. 12: 748741. PMID 34737749 DOI: 10.3389/fimmu.2021.748741 |
0.317 |
|
| 2021 |
Fu Z, Mowday AM, Smaill JB, Hermans IF, Patterson AV. Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy. Cells. 10. PMID 33923305 DOI: 10.3390/cells10051006 |
0.548 |
|
| 2021 |
Painter GF, Burn OK, Hermans IF. Using agonists for iNKT cells in cancer therapy. Molecular Immunology. 130: 1-6. PMID 33340930 DOI: 10.1016/j.molimm.2020.12.010 |
0.453 |
|
| 2020 |
Burn OK, Prasit KK, Hermans IF. Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists. Cancers. 12. PMID 33352882 DOI: 10.3390/cancers12123824 |
0.356 |
|
| 2020 |
Tang JS, Compton BJ, Marshall A, Anderson R, Li Y, van der Woude H, Hermans IF, Painter GF, Gasser O. Mānuka honey-derived methylglyoxal enhances microbial sensing by mucosal-associated invariant T cells. Food & Function. PMID 32618294 DOI: 10.1039/d0fo01153c |
0.378 |
|
| 2020 |
Holz LE, Chua YC, de Menezes MN, Anderson RJ, Draper SL, Compton BJ, Chan STS, Mathew J, Li J, Kedzierski L, Wang Z, Beattie L, Enders MH, Ghilas S, May R, ... ... Hermans IF, et al. Glycolipid-peptide vaccination induces liver-resident memory CD8 T cells that protect against rodent malaria. Science Immunology. 5. PMID 32591409 DOI: 10.1126/sciimmunol.aaz8035 |
0.391 |
|
| 2020 |
Li Y, Woods K, Parry-Strong A, Anderson RJ, Capistrano C, Gestin A, Painter GF, Hermans IF, Krebs J, Gasser O. Distinct Dysfunctional States of Circulating Innate-Like T Cells in Metabolic Disease. Frontiers in Immunology. 11: 448. PMID 32231670 DOI: 10.3389/fimmu.2020.00448 |
0.353 |
|
| 2020 |
George P, Dasyam N, Giunti G, Mester B, Bauer E, Andrews B, Perera T, Ostapowicz T, Frampton C, Li P, Ritchie D, Bollard CM, Hermans IF, Weinkove R. Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE). Bmj Open. 10: e034629. PMID 32041862 DOI: 10.1136/bmjopen-2019-034629 |
0.342 |
|
| 2020 |
Ferrer-Font L, Mehta P, Harmos P, Schmidt AJ, Chappell S, Price KM, Hermans IF, Ronchese F, le Gros G, Mayer JU. High-dimensional analysis of intestinal immune cells during helminth infection. Elife. 9. PMID 32041687 DOI: 10.7554/eLife.51678 |
0.319 |
|
| 2020 |
Lange J, Anderson RJ, Marshall AJ, Chan ST, Bilbrough TS, Gasser O, Gonzalez-Lopez C, Salio M, Cerundolo V, Hermans IF, Painter GF. The chemical synthesis, stability and activity of MAIT cell prodrug agonists that access MR1 in recycling endosomes. Acs Chemical Biology. PMID 31909966 DOI: 10.1021/Acschembio.9B00902 |
0.308 |
|
| 2019 |
Compton BJ, Farrand KJ, Tang CW, Osmond TL, Speir M, Authier-Hall A, Wang J, Ferguson PM, Chan STS, Anderson RJ, Cooney TR, Hayman CM, Williams GM, Brimble MA, Brooks CR, ... ... Hermans IF, et al. Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist. Organic & Biomolecular Chemistry. PMID 30656346 DOI: 10.1039/C8Ob02982B |
0.472 |
|
| 2019 |
George P, Mester B, Dasyam N, Giunti G, Le Q, Hermans I, Li P, Weinkove R. THIRD GENERATION CAR T-CELL THERAPY UTILISING TOLL LIKE RECEPTOR 2 CO-STIMULATION Hematological Oncology. 37: 517-517. DOI: 10.1002/hon.202_2631 |
0.312 |
|
| 2018 |
Prendergast KA, Daniels NJ, Petersen TR, Hermans IF, Kirman JR. Langerin CD8α Dendritic Cells Drive Early CD8 T Cell Activation and IL-12 Production During Systemic Bacterial Infection. Frontiers in Immunology. 9: 953. PMID 29867941 DOI: 10.3389/fimmu.2018.00953 |
0.37 |
|
| 2017 |
Field CS, Hunn MK, Ferguson PM, Ruedl C, Ancelet LR, Hermans IF. Blocking CTLA-4 while priming with a whole cell vaccine reshapes the oligoclonal T cell infiltrate and eradicates tumors in an orthotopic glioma model. Oncoimmunology. 7: e1376154. PMID 29296535 DOI: 10.1080/2162402X.2017.1376154 |
0.476 |
|
| 2017 |
Gasser O, Sharples KJ, Barrow C, Williams GM, Bauer E, Wood CE, Mester B, Dzhelali M, Caygill G, Jones J, Hayman CM, Hinder VA, Macapagal J, McCusker M, Weinkove R, ... ... Hermans IF, et al. A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients. Cancer Immunology, Immunotherapy : Cii. PMID 29094183 DOI: 10.1007/S00262-017-2085-9 |
0.486 |
|
| 2017 |
Speir M, Authier-Hall A, Brooks CR, Farrand KJ, Compton BJ, Anderson RJ, Heiser A, Osmond TL, Tang CW, Berzofsky JA, Terabe M, Painter GF, Hermans IF, Weinkove R. Glycolipid-peptide conjugate vaccines enhance CD8(+) T cell responses against human viral proteins. Scientific Reports. 7: 14273. PMID 29079845 DOI: 10.1038/s41598-017-14690-5 |
0.415 |
|
| 2017 |
Anderson RJ, Li J, Kedzierski L, Compton BJ, Hayman CM, Osmond TL, Tang CW, Farrand KJ, Koay HF, Almeida CFDSSE, Holz LR, Williams GM, Brimble MA, Wang Z, Koutsakos M, ... ... Hermans IF, et al. Augmenting influenza-specific T cell memory generation with a NKT cell-dependent glycolipid-peptide vaccine. Acs Chemical Biology. PMID 29043774 DOI: 10.1021/Acschembio.7B00845 |
0.375 |
|
| 2017 |
Salio M, Gasser O, Gonzalez-Lopez C, Martens A, Veerapen N, Gileadi U, Verter JG, Napolitani G, Anderson R, Painter G, Besra GS, Hermans IF, Cerundolo V. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 28877992 DOI: 10.4049/Jimmunol.1700615 |
0.42 |
|
| 2017 |
Speir M, Hermans IF, Weinkove R. Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination. Drugs. 77: 1-15. PMID 28005229 DOI: 10.1007/s40265-016-0675-z |
0.477 |
|
| 2015 |
Anderson RJ, Compton BJ, Tang CW, Authier-Hall A, Hayman CM, Swinerd GW, Kowalczyk R, Harris P, Brimble MA, Larsen DS, Gasser O, Weinkove R, Hermans IF, Painter GF. NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity. Chemical Science. 6: 5120-5127. PMID 28717498 DOI: 10.1039/C4Sc03599B |
0.394 |
|
| 2015 |
Gibbins JD, Ancelet LR, Osmond TL, Petersen TR, Hermans IF. Splenic Dendritic Cells Involved in Cross-Tolerance of Tumor Antigens Can Play a Stimulatory Role in Adoptive T-Cell Therapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 38: 321-9. PMID 26325376 DOI: 10.1097/CJI.0000000000000096 |
0.518 |
|
| 2015 |
Osmond TL, Farrand KJ, Painter GF, Ruedl C, Petersen TR, Hermans IF. Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming. Journal of Immunology (Baltimore, Md. : 1950). PMID 26078270 DOI: 10.4049/jimmunol.1401751 |
0.44 |
|
| 2015 |
Hunn MK, Bauer E, Wood CE, Gasser O, Dzhelali M, Ancelet LR, Mester B, Sharples KJ, Findlay MP, Hamilton DA, Hermans IF. Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme. Journal of Neuro-Oncology. 121: 319-29. PMID 25366363 DOI: 10.1007/s11060-014-1635-7 |
0.351 |
|
| 2015 |
Authier A, Farrand KJ, Broadley KW, Ancelet LR, Hunn MK, Stone S, McConnell MJ, Hermans IF. Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells. International Journal of Cancer. Journal International Du Cancer. 136: 2566-78. PMID 25363661 DOI: 10.1002/ijc.29309 |
0.458 |
|
| 2014 |
Anderson RJ, Tang CW, Daniels NJ, Compton BJ, Hayman CM, Johnston KA, Knight DA, Gasser O, Poyntz HC, Ferguson PM, Larsen DS, Ronchese F, Painter GF, Hermans IF. A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy. Nature Chemical Biology. 10: 943-9. PMID 25282504 DOI: 10.1038/nchembio.1640 |
0.419 |
|
| 2014 |
Gibbins JD, Ancelet LR, Weinkove R, Compton BJ, Painter GF, Petersen TR, Hermans IF. An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment. Blood. 124: 2953-63. PMID 25237205 DOI: 10.1182/blood-2014-04-568956 |
0.455 |
|
| 2014 |
Prendergast KA, Osmond TL, Ochiai S, Hermans IF, Kirman JR. Sustained in vivo depletion of splenic langerin(+) CD8α(+) dendritic cells is well-tolerated by lang-DTREGFP mice. Journal of Immunological Methods. 406: 104-9. PMID 24556588 DOI: 10.1016/j.jim.2014.02.005 |
0.366 |
|
| 2013 |
Weinkove R, Brooks CR, Carter JM, Hermans IF, Ronchese F. Efficient depletion of chronic lymphocytic leukemia B cells using serial rounds of immunomagnetic depletion. Journal of Immunological Methods. 396: 152-6. PMID 23911312 DOI: 10.1016/j.jim.2013.07.004 |
0.354 |
|
| 2013 |
Ataera H, Simkins HM, Hyde E, Yang J, Hermans IF, Petersen TR, Ronchese F. The control of CD8+ T cell responses is preserved in perforin-deficient mice and released by depletion of CD4+CD25+ regulatory T cells. Journal of Leukocyte Biology. 94: 825-33. PMID 23883515 DOI: 10.1189/jlb.0413200 |
0.439 |
|
| 2013 |
Hunn MK, Hermans IF. Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines. Oncoimmunology. 2: e23789. PMID 23734325 DOI: 10.4161/onci.23789 |
0.484 |
|
| 2013 |
Ferguson PM, Slocombe A, Tilley RD, Hermans IF. Using magnetic resonance imaging to evaluate dendritic cell-based vaccination. Plos One. 8: e65318. PMID 23734246 DOI: 10.1371/journal.pone.0065318 |
0.344 |
|
| 2013 |
Weinkove R, Brooks CR, Carter JM, Hermans IF, Ronchese F. Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy. Haematologica. 98: 376-84. PMID 23065503 DOI: 10.3324/haematol.2012.072835 |
0.425 |
|
| 2012 |
Hunn MK, Farrand KJ, Broadley KW, Weinkove R, Ferguson P, Miller RJ, Field CS, Petersen T, McConnell MJ, Hermans IF. Vaccination with irradiated tumor cells pulsed with an adjuvant that stimulates NKT cells is an effective treatment for glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6446-59. PMID 23147997 DOI: 10.1158/1078-0432.CCR-12-0704 |
0.327 |
|
| 2012 |
Dangerfield EM, Cheng JM, Knight DA, Weinkove R, Dunbar PR, Hermans IF, Timmer MS, Stocker BL. Species-specific activity of glycolipid ligands for invariant NKT cells. Chembiochem : a European Journal of Chemical Biology. 13: 1349-56. PMID 22639457 DOI: 10.1002/cbic.201200095 |
0.315 |
|
| 2012 |
McKee SJ, Young VL, Clow F, Hayman CM, Baird MA, Hermans IF, Young SL, Ward VK. Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses. Journal of Controlled Release : Official Journal of the Controlled Release Society. 159: 338-45. PMID 22386518 DOI: 10.1016/j.jconrel.2012.02.015 |
0.41 |
|
| 2011 |
Petersen TR, Sika-Paotonu D, Knight DA, Simkins HM, Hermans IF. Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines. Plos One. 6: e17657. PMID 21483862 DOI: 10.1371/journal.pone.0017657 |
0.47 |
|
| 2011 |
Simkins HM, Hyde E, Farrand KJ, Ong ML, Degli-Esposti MA, Hermans IF, Ronchese F. Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo. Journal of Leukocyte Biology. 89: 753-62. PMID 21297009 DOI: 10.1189/jlb.0910480 |
0.336 |
|
| 2011 |
Girvan RC, Knight DA, O'Loughlin CJ, Hayman CM, Hermans IF, Webster GA. MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity. Vaccine. 29: 545-57. PMID 21034827 DOI: 10.1016/j.vaccine.2010.10.040 |
0.43 |
|
| 2010 |
Petersen TR, Dickgreber N, Hermans IF. Tumor antigen presentation by dendritic cells. Critical Reviews in Immunology. 30: 345-86. PMID 20666707 |
0.502 |
|
| 2010 |
Petersen TR, Sika-Paotonu D, Knight DA, Dickgreber N, Farrand KJ, Ronchese F, Hermans IF. Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand. Immunology and Cell Biology. 88: 596-604. PMID 20142835 DOI: 10.1038/icb.2010.9 |
0.553 |
|
| 2009 |
Farrand KJ, Dickgreber N, Stoitzner P, Ronchese F, Petersen TR, Hermans IF. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens. Journal of Immunology (Baltimore, Md. : 1950). 183: 7732-42. PMID 19923446 DOI: 10.4049/jimmunol.0902707 |
0.351 |
|
| 2009 |
Tripp CH, Sparber F, Hermans IF, Romani N, Stoitzner P. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 7644-54. PMID 19494288 DOI: 10.4049/jimmunol.0900134 |
0.351 |
|
| 2009 |
Dickgreber N, Stoitzner P, Bai Y, Price KM, Farrand KJ, Manning K, Angel CE, Dunbar PR, Ronchese F, Fraser JD, Bäckström BT, Hermans IF. Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy. Journal of Immunology (Baltimore, Md. : 1950). 182: 1260-9. PMID 19155471 |
0.345 |
|
| 2008 |
Andrew KA, Simkins HM, Witzel S, Perret R, Hudson J, Hermans IF, Ritchie DS, Yang J, Ronchese F. Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo. Journal of Immunology (Baltimore, Md. : 1950). 181: 8356-62. PMID 19050252 |
0.342 |
|
| 2008 |
Stoitzner P, Green LK, Jung JY, Price KM, Tripp CH, Malissen B, Kissenpfennig A, Hermans IF, Ronchese F. Tumor immunotherapy by epicutaneous immunization requires langerhans cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 1991-8. PMID 18209098 |
0.446 |
|
| 2007 |
Matthews KE, Qin JS, Yang J, Hermans IF, Palmowski MJ, Cerundolo V, Ronchese F. Increasing the survival of dendritic cells in vivo does not replace the requirement for CD4+ T cell help during primary CD8+ T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 179: 5738-47. PMID 17947646 DOI: 10.4049/Jimmunol.179.9.5738 |
0.371 |
|
| 2007 |
Hermans IF, Silk JD, Gileadi U, Masri SH, Shepherd D, Farrand KJ, Salio M, Cerundolo V. Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. Journal of Immunology (Baltimore, Md. : 1950). 178: 2721-9. PMID 17312114 DOI: 10.4049/Jimmunol.178.5.2721 |
0.366 |
|
| 2006 |
Lee A, Farrand KJ, Dickgreber N, Hayman CM, Jürs S, Hermans IF, Painter GF. Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity. Carbohydrate Research. 341: 2785-98. PMID 17014832 DOI: 10.1016/j.carres.2006.09.006 |
0.316 |
|
| 2006 |
Matthews KE, Hermans IF, Roberts JM, Ching LM, Ronchese F. 5,6-Dimethylxanthenone-4-acetic acid treatment of a non-immunogenic tumour does not synergize with active or passive CD8+ T-cell immunotherapy. Immunology and Cell Biology. 84: 383-9. PMID 16834573 DOI: 10.1111/j.1440-1711.2006.01448.x |
0.467 |
|
| 2006 |
Ritchie D, Hermans I, Yang J, Walton J, Matthews K, Carter J, Findlay M, Dady P, Rawson P, Ronchese F. Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies. Leukemia & Lymphoma. 47: 675-82. PMID 16690526 DOI: 10.1080/10428190500376365 |
0.33 |
|
| 2006 |
Yang J, Huck SP, McHugh RS, Hermans IF, Ronchese F. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. Proceedings of the National Academy of Sciences of the United States of America. 103: 147-52. PMID 16373503 DOI: 10.1073/pnas.0509054103 |
0.458 |
|
| 2005 |
Chong TW, Salio M, Hermans IF, Harris AL, Cerundolo V. Analysis of renal cell cancer tumour antigen carbonic anhydrase 9 specific cytotoxic T lymphocytes from a healthy HLA-A2 donor The Journal of Urology. 173: 96-96. DOI: 10.1016/S0022-5347(18)34605-6 |
0.433 |
|
| 2004 |
Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, Mathew B, Schmidt RR, Lunt SJ, Williams KJ, Stratford IJ, Harris AL, Cerundolo V. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. The Journal of Clinical Investigation. 114: 1800-11. PMID 15599405 DOI: 10.1172/Jci200422046 |
0.568 |
|
| 2004 |
Ritchie DS, Yang J, Hermans IF, Ronchese F. B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells. Scandinavian Journal of Immunology. 60: 543-51. PMID 15584965 DOI: 10.1111/j.0300-9475.2004.01517.x |
0.464 |
|
| 2004 |
Salio M, Palmowski MJ, Atzberger A, Hermans IF, Cerundolo V. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. The Journal of Experimental Medicine. 199: 567-79. PMID 14970182 DOI: 10.1084/Jem.20031059 |
0.444 |
|
| 2004 |
Hermans IF, Silk JD, Yang J, Palmowski MJ, Gileadi U, McCarthy C, Salio M, Ronchese F, Cerundolo V. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. Journal of Immunological Methods. 285: 25-40. PMID 14871532 DOI: 10.1016/J.Jim.2003.10.017 |
0.334 |
|
| 2004 |
Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, Mathew B, Schmidt RR, Lunt SJ, Williams KJ, Stratford IJ, Harris AL, Cerundolo V. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy Journal of Clinical Investigation. 114: 1800-1811. DOI: 10.1172/JCI200422046 |
0.477 |
|
| 2003 |
Hermans IF, Chong TW, Palmowski MJ, Harris AL, Cerundolo V. Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model. Cancer Research. 63: 8408-13. PMID 14679003 |
0.543 |
|
| 2003 |
Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 171: 5140-7. PMID 14607913 DOI: 10.4049/Jimmunol.171.10.5140 |
0.562 |
|
| 2003 |
Choi EM, Chen JL, Wooldridge L, Salio M, Lissina A, Lissin N, Hermans IF, Silk JD, Mirza F, Palmowski MJ, Dunbar PR, Jakobsen BK, Sewell AK, Cerundolo V. High avidity antigen-specific CTL identified by CD8-independent tetramer staining. Journal of Immunology (Baltimore, Md. : 1950). 171: 5116-23. PMID 14607910 DOI: 10.4049/Jimmunol.171.10.5116 |
0.418 |
|
| 2002 |
Palmowski MJ, Choi EM, Hermans IF, Gilbert SC, Chen JL, Gileadi U, Salio M, Van Pel A, Man S, Bonin E, Liljestrom P, Dunbar PR, Cerundolo V. Competition between CTL narrows the immune response induced by prime-boost vaccination protocols. Journal of Immunology (Baltimore, Md. : 1950). 168: 4391-8. PMID 11970981 DOI: 10.4049/Jimmunol.168.9.4391 |
0.32 |
|
| 2001 |
Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans I, Hemmi S, Hengartner H, Zinkernagel RM. Erratum: Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction Nature. 413: 183-183. DOI: 10.1038/35093138 |
0.313 |
|
| 2000 |
Ritchie DS, Hermans IF, Lumsden JM, Scanga CB, Roberts JM, Yang J, Kemp RA, Ronchese F. Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. Journal of Immunological Methods. 246: 109-17. PMID 11121552 DOI: 10.1016/S0022-1759(00)00300-8 |
0.349 |
|
| 2000 |
Hermans IF, Ritchie DS, Yang J, Roberts JM, Ronchese F. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 164: 3095-101. PMID 10706699 DOI: 10.4049/jimmunol.164.6.3095 |
0.391 |
|
| 1999 |
McCoy KD, Hermans IF, Fraser JH, Le Gros G, Ronchese F. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help. The Journal of Experimental Medicine. 189: 1157-62. PMID 10190907 DOI: 10.1084/jem.189.7.1157 |
0.467 |
|
| 1997 |
Hermans IF, Daish A, Moroni-Rawson P, Ronchese F. Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge. Cancer Immunology, Immunotherapy : Cii. 44: 341-7. PMID 9298937 DOI: 10.1007/s002620050392 |
0.348 |
|
| 1996 |
Garrigan K, Moroni-Rawson P, McMurray C, Hermans I, Abernethy N, Watson J, Ronchese F. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors Blood. 88: 3508-3512. DOI: 10.1182/BLOOD.V88.9.3508.BLOODJOURNAL8893508 |
0.39 |
|
| Show low-probability matches. |